期刊文献+

缬沙坦治疗老年高血压的85例临床观察 被引量:4

下载PDF
导出
摘要 目的观察缬沙坦对老年高血压的临床疗效。方法选择我门诊部收治的老年高血压患者85例,口服缬沙坦50mg/d,连续治疗30d,观察治疗后血压和心率的变化和临床效果。结果治疗后患者血压均显著下降,收缩压和舒张压均小于治疗前,差异具有统计学意义(P<0.05)。治疗后85例患者中,显效70例,有效15例子,无效0例子,总有效率达到100%。血生化及血液流变学指标治疗前后比较无显著性差异(均P>0.05)。85例患者中,仅有2例出现轻微不良反应,感到轻微头痛,症状无需治疗自行消失。结论缬沙坦在治疗老年高血压方面降压效果好,值得临床推广。
作者 蔡金梅
出处 《中外医疗》 2011年第22期130-130,共1页 China & Foreign Medical Treatment
  • 相关文献

参考文献5

二级参考文献32

  • 1Rose M, Mc Mabon FG. Some problems with antihypertensive drug studies in the context of the new guidelines [ J ]. Am Hypertens, 1990.3:151,294-296. 被引量:1
  • 2谢惠民.合理用药(第4版)[M].北京:人民卫生出版社,2004.332. 被引量:4
  • 3Julius S, Kjeldsen SE, Weber M, et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial [J]. Lancet, 2004, 363:2022-2031. 被引量:1
  • 4Sever P. The VALUE trial: a commentary [J]. J Renin Angiotensin Aldosterone Syst, 2004, 5 ( 3 ): 99-101. 被引量:1
  • 5Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention,Detection, Evaluation, and Treatment of High Blood Pressure:the JNC 7 report [J]. JAMA, 2003, 289:2560-2572. 被引量:1
  • 6Guidelines Committee. 2003 European Society of HypertensionEuropean Society of Cardiology guidelines for the management of arterial hypertension [J]. J Hypertens, 2003, 21:1011-1053. 被引量:1
  • 7WHO, International Society of Hypertension Writing Group.2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension[J]. J Hypertens, 2003, 21:1983-1992. 被引量:1
  • 8Weber MA, Julius S, Kjeldsen SE,et al. Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial [J]. Lancet, 2004, 363:2049-2051. 被引量:1
  • 9Furberg CD, Wright JT, Davis BR, et al. Major outcomes in high-risk hypertensive patients randomised to angiotensinconverting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) [J]. JAMA, 2002, 288:2981-2997. 被引量:1
  • 10Dahlof B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol [J]. Lancet, 2002, 359:995-1003. 被引量:1

共引文献24

同被引文献19

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部